Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats
| dc.creator | Juliana Barbosa Saliba | |
| dc.creator | Rodrigo Lambert Oréfice | |
| dc.creator | Meriem Tekaya | |
| dc.creator | Laura Kowalczuk | |
| dc.creator | Min Zhao | |
| dc.creator | Francine Behar-Cohen | |
| dc.creator | Lorena Carla Vieira | |
| dc.creator | Gabriella Maria Fernandes Cunha | |
| dc.creator | Gisele Rodrigues da Silva | |
| dc.creator | Sílvia Ligório Fialho | |
| dc.creator | Armando da Silva Cunha Júnior | |
| dc.creator | Elodie Bousquet | |
| dc.creator | Marie-Christine Naud | |
| dc.creator | Eliane Ayres | |
| dc.date.accessioned | 2024-03-05T17:55:14Z | |
| dc.date.accessioned | 2025-09-09T00:54:29Z | |
| dc.date.available | 2024-03-05T17:55:14Z | |
| dc.date.issued | 2016-04 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.1167/iovs.15-18127 | |
| dc.identifier.issn | 0146-0404 | |
| dc.identifier.uri | https://hdl.handle.net/1843/65285 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Investigative Ophthalmology & Visual Science | |
| dc.rights | Acesso Aberto | |
| dc.subject | Implantes de medicamento | |
| dc.subject | Uveíte | |
| dc.subject | Oftalmopatias | |
| dc.subject | Uveíte induzido quimicamente | |
| dc.subject.other | Polyurethane | |
| dc.subject.other | Implant | |
| dc.subject.other | Suprachoroidal space | |
| dc.subject.other | Drug delivery | |
| dc.subject.other | Endotoxin-induced uveitis | |
| dc.title | Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 1679 | |
| local.citation.issue | 4 | |
| local.citation.spage | 1671 | |
| local.citation.volume | 57 | |
| local.description.resumo | PURPOSE. Targeted drug delivery to the ocular tissues remains a challenge. Biodegradable intraocular implants allow prolonged controlled release of drugs directly into the eye. In this study, we evaluated an anterior suprachoroidal polyurethane implant containing dexamethasone polyurethane dispersions (DX-PUD) as a drug delivery system in the rat model of endotoxin-induced uveitis (EIU). METHODS. In vitro drug release was studied using PUD implants containing 8%, 20%, and 30% (wt/wt) DX. Cytotoxicity of the degradation products of DX-PUD was assessed on human ARPE19 cells using 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) test. Shortterm ocular biocompatibility of suprachoroidal DX-PUD implants was evaluated in normal rat eyes. Endotoxin-induced uveitis was then induced in rat eyes preimplanted with DX-PUD. Clinical examination was performed at 24 hours; eyes were used to assess inflammatory cell infiltration and macrophage/microglial activation. Cytokine and chemokine expression in the iris/ciliary body and in the retina was investigated using quantitative PCR. Feasibility of anterior suprachoroidal PUD implantation was also tested using postmortem human eyes. RESULTS. A burst release was followed by a sustained controlled release of DX from PUD implants. By-products of the DX-PUD were not toxic to human ARPE-19 cells or to rat ocular tissues. Dexamethasone-PUD implants prevented EIU in rat eyes, reducing inflammatory cell infiltration and inhibiting macrophage/microglial activation. Dexamethasone-PUD downregulated proinflammatory cytokines/chemokines (IL-1b, IL-6, cytokine-induced neutrophil chemoattractant [CINC]) and inducible nitric oxide synthase (iNOS) and upregulated IL-10 anti-inflammatory cytokine. Polyurethane dispersion was successfully implanted into postmortem human eyes. CONCLUSIONS. Dexamethasone-PUD implanted in the anterior suprachoroidal space may be of interest in the treatment of intraocular inflammation. | |
| local.publisher.country | Brasil | |
| local.publisher.department | ENG - DEPARTAMENTO DE ENGENHARIA METALÚRGICA | |
| local.publisher.department | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://iovs.arvojournals.org/article.aspx?articleid=2513119&resultClick=1 |